{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:14:00Z","timestamp":1788088440142,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,30]]},"DOI":"10.7759\/cureus.115424","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T10:16:20Z","timestamp":1788084980000},"source":"Crossref","is-referenced-by-count":0,"title":["Patterns and Frequency of Opioid Use Among Individuals With a History of Gastrointestinal Malignancy: A Cross-Sectional Analysis of the 2019-2020 National Health Interview Survey (NHIS)"],"prefix":"10.7759","author":[{"given":"Mohammed D","family":"Al-Hejaili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazi H","family":"Mogharbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana F","family":"Maufa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmohsen","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisa","family":"Manfaluti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifq S","family":"Altamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linah  A","family":"Murtadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman I","family":"Almarwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad K","family":"Alandejane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70245","article-title":"Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries","volume":"132","author":"Danpanichkul P","year":"2026","unstructured":"Danpanichkul P, Pang Y, Tothanarungroj P, et al.. Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries. Cancer. 2026, 132:e70245. 10.1002\/cncr.70245","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00366-7","article-title":"Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN","volume":"9","author":"Wang S","year":"2024","unstructured":"Wang S, Zheng R, Li J, et al.. Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN. Lancet Gastroenterol Hepatol. 2024, 9:229-37. 10.1016\/S2468-1253(23)00366-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis","volume":"51","author":"van den Beuken-van Everdingen MH","year":"2016","unstructured":"van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016, 51:1070-1090.e9. 10.1016\/j.jpainsymman.2015.12.340","journal-title":"J Pain Symptom Manage"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4610","article-title":"Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015","volume":"11","author":"Lu Z","year":"2022","unstructured":"Lu Z, Zhang N, Giordano SH, Zhao H. Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015. Cancer Med. 2022, 11:2296-307. 10.1002\/cam4.4610","journal-title":"Cancer Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15435-1","article-title":"Long-term health outcomes of new persistent opioid use after gastrointestinal cancer surgery","volume":"31","author":"Khalil M","year":"2024","unstructured":"Khalil M, Woldesenbet S, Munir MM, et al.. Long-term health outcomes of new persistent opioid use after gastrointestinal cancer surgery. Ann Surg Oncol. 2024, 31:5283-92. 10.1245\/s10434-024-15435-1","journal-title":"Ann Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7382","article-title":"Outcomes of patients with advanced gastrointestinal cancer in relationship to opioid use: findings from eight clinical trials","volume":"18","author":"Abdel-Rahman O","year":"2020","unstructured":"Abdel-Rahman O, Karachiwala H, Easaw JC. Outcomes of patients with advanced gastrointestinal cancer in relationship to opioid use: findings from eight clinical trials. J Natl Compr Canc Netw. 2020, 18:575-81. 10.6004\/jnccn.2019.7382","journal-title":"J Natl Compr Canc Netw"},{"key":"ref7","unstructured":"Centers for Disease Control and Prevention (CDC). The National Health Interview Survey (NHIS). (2026). Accessed. July 18, 2026: https:\/\/www.cdc.gov\/nchs\/nhis."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S145450","article-title":"Hepatocellular cancer pain: impact and management challenges","volume":"5","author":"Christian-Miller N","year":"2018","unstructured":"Christian-Miller N, Frenette C. Hepatocellular cancer pain: impact and management challenges. J Hepatocell Carcinoma. 2018, 5:75-80. 10.2147\/JHC.S145450","journal-title":"J Hepatocell Carcinoma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.17998\/jlc.2026.03.19","article-title":"Pain, analgesic use and misconceptions in patients with hepatocellular carcinoma: a cross-sectional survey","volume":"[Online ahead of press]","author":"Park J","year":"2026","unstructured":"Park J, Yang J, Chung SW, et al.. Pain, analgesic use and misconceptions in patients with hepatocellular carcinoma: a cross-sectional survey. J Liver Cancer. 2026, [Online ahead of press]:10.17998\/jlc.2026.03.19","journal-title":"J Liver Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4488-z","article-title":"Pain in patients with pancreatic cancer: prevalence, mechanisms, management and future developments","volume":"62","author":"Koulouris AI","year":"2017","unstructured":"Koulouris AI, Banim P, Hart AR. Pain in patients with pancreatic cancer: prevalence, mechanisms, management and future developments. Dig Dis Sci. 2017, 62:861-70. 10.1007\/s10620-017-4488-z","journal-title":"Dig Dis Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30030257","article-title":"Persisting deficits in health-related quality of life of colorectal cancer survivors 14-24 years post-diagnosis: a population-based study","volume":"30","author":"Thong MS","year":"2023","unstructured":"Thong MS, Doege D, Wei\u00dfer L, et al.. Persisting deficits in health-related quality of life of colorectal cancer survivors 14-24 years post-diagnosis: a population-based study. Curr Oncol. 2023, 30:3373-90. 10.3390\/curroncol30030257","journal-title":"Curr Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.9043","article-title":"The 2016 CDC opioid guideline and analgesic prescribing patterns in older adults with cancer","volume":"8","author":"Rodin R","year":"2025","unstructured":"Rodin R, Li L, McKendrick K, et al.. The 2016 CDC opioid guideline and analgesic prescribing patterns in older adults with cancer. JAMA Netw Open. 2025, 8:e259043. 10.1001\/jamanetworkopen.2025.9043","journal-title":"JAMA Netw Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz329","article-title":"A biopsychosocial model of chronic pain for older adults","volume":"21","author":"Miaskowski C","year":"2020","unstructured":"Miaskowski C, Blyth F, Nicosia F, Haan M, Keefe F, Smith A, Ritchie C. A biopsychosocial model of chronic pain for older adults. Pain Med. 2020, 21:1793-805. 10.1093\/pm\/pnz329","journal-title":"Pain Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00476","article-title":"US trends in opioid access among patients with poor prognosis cancer near the end-of-life","volume":"39","author":"Enzinger AC","year":"2021","unstructured":"Enzinger AC, Ghosh K, Keating NL, Cutler DM, Landrum MB, Wright AA. US trends in opioid access among patients with poor prognosis cancer near the end-of-life. J Clin Oncol. 2021, 39:2948-58. 10.1200\/JCO.21.00476","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2024.104707","article-title":"The association between smoking, chronic pain, and prescription opioid use: 2013-2021","volume":"26","author":"Encinosa W","year":"2025","unstructured":"Encinosa W, Bernard D, Valdez RB. The association between smoking, chronic pain, and prescription opioid use: 2013-2021. J Pain. 2025, 26:104707. 10.1016\/j.jpain.2024.104707","journal-title":"J Pain"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107901","article-title":"Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain","volume":"209","author":"Cheatle MD","year":"2020","unstructured":"Cheatle MD, Falcone M, Dhingra L, Lerman C. Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain. Drug Alcohol Depend. 2020, 209:107901. 10.1016\/j.drugalcdep.2020.107901","journal-title":"Drug Alcohol Depend"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241290769","article-title":"Prescription opioid use before and after diagnosis of cancer among older cancer survivors with non-cancer chronic pain conditions (NCPCs): an application of group-based trajectory modeling (GBTM)","volume":"31","author":"Safarudin R","year":"2024","unstructured":"Safarudin R, LeMasters T, Khan S, Sambamoorthi U. Prescription opioid use before and after diagnosis of cancer among older cancer survivors with non-cancer chronic pain conditions (NCPCs): an application of group-based trajectory modeling (GBTM). Cancer Control. 2024, 31:10732748241290769. 10.1177\/10732748241290769","journal-title":"Cancer Control"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/526871-patterns-and-frequency-of-opioid-use-among-individuals-with-a-history-of-gastrointestinal-malignancy-a-cross-sectional-analysis-of-the-2019-2020-national-health-interview-survey-nhis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T10:16:22Z","timestamp":1788084982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/526871-patterns-and-frequency-of-opioid-use-among-individuals-with-a-history-of-gastrointestinal-malignancy-a-cross-sectional-analysis-of-the-2019-2020-national-health-interview-survey-nhis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.115424","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,30]]}}}